The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Cancer Stem Cells and Advanced Novel Technologies in Oncotherapy
|
|
Author(s): Shalini Sakthivel (Department of Bio-Medical Science, Bharathidasan University, India), Manjita Srivastava (National Institute of Virology (ICMR), India), Muneesh Kumar Barman (Laboratory for HIV Research, National Centre for Cell Sciences, Pune, India), Nerethika Ravichandiran (Department of Bio-Medical Science, Bharathidasan University, India), Salonee Martins (National Institute of Virology (ICMR), India), Meenakshi Singh (Transplant Immunology and Immunogenetics Lab (HLA), ACTREC, Tata Memorial Centre, India), Kailash Chand (National Centre for Cell Sciences, Pune, India), Subash C. Sonkar (Multidisciplinary Research Unit, Department of Biochemistry, New Delhi, India)and Prudhvilal Bhukya (National Institute of Virology (ICMR), Pune, India)
Copyright: 2024
Pages: 29
Source title:
Research Anthology on Bioinformatics, Genomics, and Computational Biology
Source Author(s)/Editor(s): Information Resources Management Association (USA)
DOI: 10.4018/979-8-3693-3026-5.ch020
Purchase
|
Abstract
Self-renewal is the most important property of stem cells. Parallel to this, cancer stem cells (CSCs) have an indefinite proliferative ability that drives tumorigenesis. The conventional treatment of cancer includes chemotherapy, radiotherapy, and surgery, which decreases the tumour size. Contrary, targeted therapy against CSCs initially does not shrink the tumour but ultimately causes tumour degeneration. Nanobiotechnology, RNA interference, microRNA are emerging fields with a vital role in targeted therapy against CSCs. The non-protein encoding microRNAs has a major role in cancer treatment since they regulate gene expression during post-transcription. RNAi technology can silence the gene of interest with potency and specificity inhibiting tumour growth. In nanoparticles-based RNA interference, nanocarriers protect RNAi molecules from immune recognition and enzymatic degradation. The cancer cell gene expression profiling using next-generation sequencing helps in understanding the underlying cancer cell mechanisms. The current chapter deals with novel concepts in the treatment of cancer.
Related Content
|
Alessandra Lima da Silva, Diego Mariano, Mariana Parise, Angie L. A. Puelles, Tatiane Senna Bialves, Luana Luiza Bastos, Lucas Santos, Rafael Pereira Lemos.
© 2025.
22 pages.
|
|
Seyyed Mohammad Amin Mousavi Sagharchi, Mohsen Sheykhhasan, Atousa Ghorbani, Elina Afrazeh, Naresh Poondla, Naser Kalhor, Hamid Tanzadehpanah, Hanie Mahaki, Hamed Manoochehri.
© 2025.
46 pages.
|
|
Eduarda Guimarães Sousa, Lucas Gabriel Rodrigues Gomes, Fernanda Diniz Prates, Talita Pereira Gomes, Gabriel Camargos Gomes, Janaíne Aparecida de Paula, Ana Lua de Oliveira Vinhal, Bernardo Buhr Alves Mendonça, Mariana Letícia Costa Pedrosa, Luiza Pereira Reis, Aline Ferreira Maciel de Oliveira, Marcus Vinicius Canário Viana, Arun Kumar Jaiswal, Siomar de Castro Soares, Vasco Ariston de Carvalho Azevedo.
© 2025.
38 pages.
|
|
Diego Mariano, Lucas Moraes dos Santos, Raquel Cardoso de Melo-Minardi.
© 2025.
30 pages.
|
|
Alessandra G. Cioletti, Frederico C. Carvalho, Lucas M. Dos Santos, Raquel C. M. Minardi.
© 2025.
32 pages.
|
|
Leandro Morais de Oliveira, Luana Luiza Bastos, Vivian Morais Paixão, Leticia Aparecida Gontijo, Tatiane Senna Bialves, Diego Mariano, Raquel Cardoso de Melo Minardi.
© 2025.
40 pages.
|
|
Angie Atoche Puelles, Luana Luiza Bastos, Vivian Morais Paixão, Sheila Cruz Araujo, Raquel Cardoso de Melo Minardi.
© 2025.
28 pages.
|
|
|